| 11th Jan 2023 7:00 am |
RNS |
Acquisition of Winterlight Labs Inc |
| 24th Nov 2022 7:00 am |
RNS |
Strategic Partnership for Chinese Market Expansion |
| 19th Oct 2022 7:00 am |
RNS |
£1.1 million eCOA contract win |
| 12th Oct 2022 7:00 am |
RNS |
Acquisition of eClinicalHealth Limited |
| 20th Sep 2022 7:00 am |
RNS |
Interim Results |
| 1st Sep 2022 7:00 am |
RNS |
£2.2m neurodegenerative disease trial contract |
| 17th Aug 2022 7:00 am |
RNS |
Alzheimer’s Disease Validation for NeuroVocalix |
| 3rd Aug 2022 2:55 pm |
RNS |
Directorate Change |
| 28th Jul 2022 7:00 am |
RNS |
PTSD trials with top 10 pharma company & US DoD |
| 26th Jul 2022 7:00 am |
RNS |
Grant of Options |
| 22nd Jul 2022 11:05 am |
RNS |
Second Price Monitoring Extn |
| 22nd Jul 2022 11:00 am |
RNS |
Price Monitoring Extension |
| 22nd Jul 2022 7:00 am |
RNS |
Director/PDMR Share Purchases |
| 21st Jul 2022 7:00 am |
RNS |
Trading Update and Notice of Results |
| 14th Jul 2022 11:06 am |
RNS |
Second Price Monitoring Extn |
| 14th Jul 2022 11:00 am |
RNS |
Price Monitoring Extension |
| 30th Jun 2022 5:43 pm |
RNS |
Holding(s) in Company |
| 8th Jun 2022 3:14 pm |
RNS |
Result of AGM |
| 16th May 2022 4:35 pm |
RNS |
Posting of Annual Report & Notice of AGM |
| 12th Apr 2022 7:00 am |
RNS |
Results for the year ended 31 December 2021 |
| 6th Apr 2022 7:00 am |
RNS |
Senior Management Appointments |
| 31st Mar 2022 7:00 am |
RNS |
Notice of Results |
| 29th Mar 2022 2:06 pm |
RNS |
Second Price Monitoring Extn |
| 29th Mar 2022 2:00 pm |
RNS |
Price Monitoring Extension |
| 28th Mar 2022 4:41 pm |
RNS |
Second Price Monitoring Extn |
| 28th Mar 2022 4:35 pm |
RNS |
Price Monitoring Extension |
| 28th Mar 2022 7:00 am |
RNS |
£1 million contract for pivotal autoimmune trial |
| 24th Mar 2022 7:00 am |
RNS |
Appointment of Nominated Adviser and Joint Broker |
| 4th Feb 2022 12:06 pm |
RNS |
Holding(s) in Company |
| 2nd Feb 2022 7:00 am |
RNS |
£2.1 million contract |
| 27th Jan 2022 7:00 am |
RNS |
Trading Update |
| 10th Jan 2022 7:00 am |
RNS |
New Major Pharma Client for Schizophrenia Trials |
| 16th Dec 2021 7:00 am |
RNS |
Electronic Clinical Outcomes Assessment Contract |
| 9th Dec 2021 7:00 am |
RNS |
£1.0m Schizophrenia clinical trial contract |
| 22nd Nov 2021 11:50 am |
RNS |
Holding(s) in Company |
| 16th Nov 2021 7:00 am |
RNS |
Grant of Options |
| 2nd Nov 2021 7:00 am |
RNS |
Directorate Change |
| 26th Oct 2021 7:00 am |
RNS |
Contract for pivotal schizophrenia clinical trial |
| 6th Oct 2021 10:06 am |
RNS |
Holding(s) in Company |
| 21st Sep 2021 7:00 am |
RNS |
Interim Results |
